282 related articles for article (PubMed ID: 28029195)
1. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
Xu J; Yao G; Ru Y; Xie S
Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
[TBL] [Abstract][Full Text] [Related]
2. Lcn5 promoter directs the region-specific expression of cre recombinase in caput epididymidis of transgenic mice.
Xie S; Xu J; Ma W; Liu Q; Han J; Yao G; Huang X; Zhang Y
Biol Reprod; 2013 Mar; 88(3):71. PubMed ID: 23349236
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
4. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
5. The role of forkhead box A2 to restrict androgen-regulated gene expression of lipocalin 5 in the mouse epididymis.
Yu X; Suzuki K; Wang Y; Gupta A; Jin R; Orgebin-Crist MC; Matusik R
Mol Endocrinol; 2006 Oct; 20(10):2418-31. PubMed ID: 16740652
[TBL] [Abstract][Full Text] [Related]
6. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
[TBL] [Abstract][Full Text] [Related]
7. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
8. High-fidelity
Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
[TBL] [Abstract][Full Text] [Related]
9. Epididymis-specific lipocalin promoters.
Suzuki K; Yu X; Chaurand P; Araki Y; Lareyre JJ; Caprioli RM; Orgebin-Crist MC; Matusik RJ
Asian J Androl; 2007 Jul; 9(4):515-21. PubMed ID: 17589789
[TBL] [Abstract][Full Text] [Related]
10. Expression Patterns of Inducible Cre Recombinase Driven by Differential Astrocyte-Specific Promoters in Transgenic Mouse Lines.
Hu NY; Chen YT; Wang Q; Jie W; Liu YS; You QL; Li ZL; Li XW; Reibel S; Pfrieger FW; Yang JM; Gao TM
Neurosci Bull; 2020 May; 36(5):530-544. PubMed ID: 31828740
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.
Zhu M; Chen M; Lichtler AC; O'Keefe RJ; Chen D
Osteoarthritis Cartilage; 2008 Jan; 16(1):129-30. PubMed ID: 17888690
[TBL] [Abstract][Full Text] [Related]
12. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D
Nucleic Acids Res; 1999 Nov; 27(22):4324-7. PubMed ID: 10536138
[TBL] [Abstract][Full Text] [Related]
13. SPC-Cre-ERT2 transgenic mouse for temporal gene deletion in alveolar epithelial cells.
Gui YS; Wang L; Tian X; Feng R; Ma A; Cai B; Zhang H; Xu KF
PLoS One; 2012; 7(9):e46076. PubMed ID: 23049940
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
Jin C; McKeehan K; Wang F
Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
[TBL] [Abstract][Full Text] [Related]
15. Generation of a mouse line harboring a Bi-transgene expressing luciferase and tamoxifen-activatable creER(T2) recombinase in cartilage.
Lo Cascio L; Liu K; Nakamura H; Chu G; Lim NH; Chanalaris A; Saklatvala J; Nagase H; Bou-Gharios G
Genesis; 2014 Feb; 52(2):110-9. PubMed ID: 24339176
[TBL] [Abstract][Full Text] [Related]
16. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice.
Zhong ZA; Sun W; Chen H; Zhang H; Lay YE; Lane NE; Yao W
Bone; 2015 Dec; 81():614-619. PubMed ID: 26232373
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
[TBL] [Abstract][Full Text] [Related]
18. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis.
Zhang M; Kirsch DG
Dis Model Mech; 2015 Sep; 8(9):1155-66. PubMed ID: 26183214
[TBL] [Abstract][Full Text] [Related]
19. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
[TBL] [Abstract][Full Text] [Related]
20. Temporally controlled somatic mutagenesis in smooth muscle.
Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
